Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology
New Advisory Opinion 23-01 is similar to other arrangements the OIG has approved in the past.
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.